{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:13:30Z","timestamp":1783487610920,"version":"3.55.0"},"reference-count":24,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>This study evaluated routinely measured serum complement C3c (C3c) and complement C4 (C4) in relation to systemic inflammation, clinical and immunological phenotypes, and patient-reported outcomes (PROs) in systemic sclerosis (SSc). Seventy SSc patients fulfilling the 2013 American College of Rheumatology\/European League Against Rheumatism (ACR\/EULAR) criteria underwent same-day assessment including serum C3c, C4, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), interleukin-6 (IL-6), autoantibodies, immunosuppressive therapy and PROs. Associations were analysed using Spearman correlations and linear regression. C3c correlated strongly with CRP (rho = 0.53, p &lt; 0.001) and ESR (rho = 0.49, p &lt; 0.001) and remained independently associated with CRP (regression coefficient \u03b2 = 0.26 mg\/L per mg\/dL, 95% confidence interval [CI] 0.14\u20130.38, p &lt; 0.001) and ESR (\u03b2 = 0.32 mm\/h per mg\/dL, 95% CI 0.16\u20130.47, p &lt; 0.001), explaining ~17% and 15% of their variance. C4 showed weaker correlations with CRP (rho = 0.37, p = 0.004) and ESR (rho = 0.29, p = 0.03). Neither C3c nor C4 correlated with IL-6, modified Rodnan skin score (mRSS), interstitial lung disease (ILD), gastrointestinal involvement, SSc subset, autoantibodies, immunosuppressive therapy or PROs. C3c and C4 levels were significantly lower in patients with secondary Sj\u00f6gren\u2019s disease (SjD) than SSc-only. Serum C3c reflects acute-phase response in SSc, paralleling CRP and ESR but not clinical phenotype or patient-perceived burden, whereas C4 provides only weaker, secondary information.<\/jats:p>","DOI":"10.3390\/ijms27135839","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:55:11Z","timestamp":1782780911000},"page":"5839","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complement C3c Reflects Acute-Phase Response but Not Clinical Phenotype in Systemic Sclerosis: A Cross-Sectional Study"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3912-3518","authenticated-orcid":false,"given":"Jakub","family":"Trefler","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Connective Tissue Diseases, and Rare Diseases, National Medical Institute of the Ministry of the Interior and Administration, ul. Wo\u0142oska 137, 02-507 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pasierb","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Connective Tissue Diseases, and Rare Diseases, National Medical Institute of the Ministry of the Interior and Administration, ul. Wo\u0142oska 137, 02-507 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Lech","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Connective Tissue Diseases, and Rare Diseases, National Medical Institute of the Ministry of the Interior and Administration, ul. Wo\u0142oska 137, 02-507 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Czaplicki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Connective Tissue Diseases, and Rare Diseases, National Medical Institute of the Ministry of the Interior and Administration, ul. Wo\u0142oska 137, 02-507 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"\u017byci\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Connective Tissue Diseases, and Rare Diseases, National Medical Institute of the Ministry of the Interior and Administration, ul. Wo\u0142oska 137, 02-507 Warsaw, Poland"},{"name":"Department of Family Medicine, Medical University of Warsaw, ul. \u017bwirki i Wigury 61, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"ref_1","first-page":"126","article-title":"The role of inflammatory markers in assessment of disease activity in systemic sclerosis","volume":"36","author":"Ross","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/acr.21716","article-title":"Association of C-reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group","volume":"64","author":"Muangchan","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Utsunomiya, A., Oyama, N., and Hasegawa, M. (2020). Potential biomarkers in systemic sclerosis: A literature review and update. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113388"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Galindo-Izquierdo, M., and Pablos, J.L. (2021). Complement as a therapeutic target in systemic autoimmune diseases. Cells, 10.","DOI":"10.3390\/cells10010148"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41584-023-00981-x","article-title":"Complement therapeutics are coming of age in rheumatology","volume":"19","author":"Holers","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/anr.1780321011","article-title":"Activation of the complement system in systemic sclerosis: Relationship to clinical severity","volume":"32","author":"Senaldi","year":"1989","journal-title":"Arthritis Rheum."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13075-016-1168-x","article-title":"Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis","volume":"18","author":"Johansson","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Pellicano, C., Miglionico, M., Romaggioli, L., Colalillo, A., Vantaggio, L., Napodano, C., Call\u00e0, C., Gulli, F., Marino, M., and Basile, U. (2022). Increased complement activation in systemic sclerosis patients with skin and lung fibrosis. J. Pers. Med., 12.","DOI":"10.3390\/jpm12020284"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/03009742.2011.641583","article-title":"Clinical correlations of hypocomplementaemia in systemic sclerosis: An analysis of the EULAR Scleroderma Trial and Research group (EUSTAR) database","volume":"41","author":"Foocharoen","year":"2012","journal-title":"Scand. J. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s13075-016-1147-2","article-title":"The association of low complement with disease activity in systemic sclerosis: A prospective cohort study","volume":"18","author":"Esposito","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Foti, R., Zeppieri, M., Foti, R., Visalli, E., Amato, G., Amato, R., Dammino, E., D\u2019esposito, F., and Gagliano, C. (2024). Retinal Vascular Abnormalities and Clinical Parameters in Systemic Sclerosis. J. Clin. Med., 13.","DOI":"10.3390\/jcm13102738"},{"key":"ref_12","first-page":"375","article-title":"Pulmonary Arterial Hypertension Incidence in Patients with Systemic Sclerosis Treated with Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry","volume":"52","author":"Cacciapaglia","year":"2025","journal-title":"J. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Gagliano, C., Visalli, E., Toro, M.D., Amato, R., Panta, G., Scollo, D., Scandura, G., Ficili, S., Amato, G., and Benenati, A. (2020). Dry Eye in Systemic Sclerosis Patients: Novel Methods to Monitor Disease Activity. Diagnostics, 10.","DOI":"10.3390\/diagnostics10060404"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.3390\/cimb45100490","article-title":"Biomarkers in systemic sclerosis: An overview","volume":"45","author":"Confalonieri","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13075-021-02433-x","article-title":"Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis","volume":"23","author":"Chen","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_17","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: A simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/2397198319886496","article-title":"Patient-reported outcome instruments in clinical trials of systemic sclerosis","volume":"5","author":"Pauling","year":"2020","journal-title":"J. Scleroderma Relat. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/acr.24258","article-title":"An Update of Outcome Measures in Systemic Sclerosis","volume":"72","author":"Chang","year":"2020","journal-title":"Arthritis Care Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/annrheumdis-2017-212412","article-title":"Common measure of quality of life for people with systemic sclerosis across seven European countries: A cross-sectional study","volume":"77","author":"Ndosi","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_22","unstructured":"Cooper, H., Hedges, L.V., and Valentine, J.C. (2009). Parametric measures of effect size. The Handbook of Research Synthesis and Meta-Analysis, Russell Sage Foundation. [2nd ed.]."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/5839\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:15:59Z","timestamp":1783484159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/5839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":24,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27135839"],"URL":"https:\/\/doi.org\/10.3390\/ijms27135839","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]}}}